Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
// Pierre Mélard 1, 2, * , Yamina Idrissi 1, * Laetitia Andrique 1, 3 , Sandrine Poglio 1 , Martina Prochazkova-Carlotti 1 , Sabine Berhouet 3 , Cécile Boucher 3 , Elodie Laharanne 1, 3 , Edith Chevret 1 , Anne Pham-Ledard 1, 4 , Andréa Carla De Souza Góes 1, 5 , Véronique Guyonnet-Duperat 6 , Alice Bibeyran 6 , François Moreau-Gaudry 6, 7 , Béatrice Vergier 1, 2 , Marie Beylot-Barry 1, 4 , Jean-Philippe Merlio 1, 3 , David Cappellen 1, 3 1 Institut National de la Santé et de la Recherche Médicale (Inserm) U1053, Universitaire de Bordeaux, F-33076 Bordeaux, France 2 Service de Pathologie, Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, F-33604 Pessac, France 3 Service de Biologie des Tumeurs-Tumorothèque, Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, F-33604 Pessac, France 4 Service de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, F-33000 Bordeaux, France 5 Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, CEP 20550-013 Rio de Janeiro, Brazil 6 Plateforme de Vectorologie, Unité Mixte de Services (UMS TBM-Core), Centre National de la Recherche Scientifique (CNRS)- Institut National de la Santé et de la Recherche Médicale (Inserm)-Universitaire de Bordeaux, F-33076 Bordeaux, France 7 Biothérapies des Maladies Génétiques et Cancers, Institut National de la Santé et de la Recherche Médicale (Inserm), U1035, Universitaire de Bordeaux, F-33076 Bordeaux, France * These authors have contributed equally to this work Correspondence to: David Cappellen, email: david.cappellen@u-bordeaux.fr Jean-Philippe Merlio, email: jp.merlio@u-bordeaux.fr Keywords: T-cell lymphomas, DUSP22, silencing, mutations, tumor suppressor function Received: April 28, 2016 Accepted: August 31, 2016 Published: September 10, 2016 ABSTRACT Monoallelic 6p25.3 rearrangements associated with DUSP22 (Dual Specificity Phosphatase 22 ) gene silencing have been reported in CD30+ peripheral T-cell lymphomas (PTCL), mostly with anaplastic morphology and of cutaneous origin. However, the mechanism of second allele silencing and the putative tumor suppressor function of DUSP22 have not been investigated so far. Here, we show that the presence, in most individuals, of an inactive paralog hampers genetic and epigenetic evaluation of the DUSP22 gene. Identification of DUSP22 -specific single-nucleotide polymorphisms haplotypes and fluorescence in situ hybridization and epigenetic characterization of the paralog status led us to develop a comprehensive strategy enabling reliable identification of DUSP22 alterations. We showed that one cutaneous anaplastic large T-cell lymphomas (cALCL) case with monoallelic 6p25.3 rearrangement and DUSP22 silencing harbored exon 1 somatic mutations associated with second allele inactivation. Another cALCL case carried an intron 1 somatic splice site mutation with predicted deleterious exon skipping effect. Other tested PTCL cases with 6p25.3 rearrangement exhibited neither mutation nor deletion nor methylation accounting for silencing of the non-rearranged DUSP22 allele, thus inactivated by a so far unknown mechanism. We also characterized the expression status of four DUSP22 splice variants and found that they are all silenced in cALCL cases with 6p25.3 breakpoints. We finally showed that restoring expression of the physiologically predominant isoform in DUSP22-deficient malignant T cells inhibits cellular expansion by stimulating apoptosis and impairs soft agar clonogenicity and tumorigenicity. This study therefore shows that DUSP22 behaves as a tumor suppressor gene in PTCL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Davoli, T., Xu, A. W., Mengwasser, K. E., Sack, L. M., Yoon, J. C., Park, P. J., & Elledge, S. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.011 · Cited by 815
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Patterson, K. I., Brummer, T., O'brien, P. M., & Daly, R. J. (2009) · Biochemical Journal · doi:10.1042/bj20082234 · Cited by 744 · cited 4×
“Among other pathways [23, 24, 25, 26, 27, 28, 29], DUSP22 was previously shown to inhibit STAT3 signalling [26].”
BackgroundInfluentialIRF4 addiction in multiple myeloma
Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature · doi:10.1038/nature07064 · Cited by 730
Kaltoft, K., Bisballe, S., Dyrberg, T., Boel, E., Rasmussen, P. B., & Thestrup-Pedersen, K. (1992) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631086 · Cited by 128 · cited 11×
“Another case (#9, Supplementary Table S1) harbored a c.22-4C>A somatic intronic mutation, 4 basepairs upstream of exon 2, predicted to lead to exon 2 skipping, with deleterious frameshift effect (Figure 4A).”
BackgroundMethodInfluentialSekine, Y., Ikeda, O., Hayakawa, Y., Tsuji, S., Imoto, S., Aoki, N., Sugiyama, K., & Matsuda, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210426 · Cited by 74 · cited 3×
“Among other pathways [23, 24, 25, 26, 27, 28, 29], DUSP22 was previously shown to inhibit STAT3 signalling [26].”
Background
Cited by
Dual-Specificity Phosphatases in Immunity and Infection: An Update
Lang, R., & Raffi, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112710 · Cited by 160
Meeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
“Overexpression of DUSP22 in DUSP22-deficient malignant T-cells impeded their proliferation, as well as their growth in soft agar and tumorigenicity (558).”
BackgroundVerardo, L. L., Otto, P. I., Machado, M. A., do Carmo Panetto, J. C., Faza, D. R. D. L. R., Alves do Egito, A., Vitorino, A. S. M., Carolino, M. I. C. M., Carolino, N. P., & da Silva, M. V. G. B. (2024) · Livestock Science · doi:10.1016/j.livsci.2024.105455 · Cited by 3
Metadata
- Authors
- Mélard, P., Idrissi, Y., Andrique, L., Poglio, S., Prochazkova-Carlotti, M., Berhouet, S., Boucher, C., Laharanne, E., Chevret, E., Pham-Ledard, A., Góes, A. C. D. S., Guyonnet-Duperat, V., Bibeyran, A., Moreau-Gaudry, F., Vergier, B., Beylot-Barry, M., Merlio, J.-P., & Cappellen, D.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-09-10
- Volume
- 7
- Issue
- 42
- Pages
- 68734-68748
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2513281735
- Cited by
- 48
- References
- 5
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.